Feb 1 (Reuters) - Horizon Therapeutics said on Monday it will buy drug developer Viela Bio Inc for about $3.05 billion in an all-cash transaction. (Reporting by Trisha Roy in Bengaluru; Editing by Shinjini Ganguli)
我们的标准: 汤森路透“信任原则”
Feb 1 (Reuters) - Horizon Therapeutics said on Monday it will buy drug developer Viela Bio Inc for about $3.05 billion in an all-cash transaction. (Reporting by Trisha Roy in Bengaluru; Editing by Shinjini Ganguli)
我们的标准: 汤森路透“信任原则”